Your browser doesn't support javascript.
loading
Rh-Endostatin Plus Irinotecan/Cisplatin as Second-Line Therapy for Advanced Esophageal Squamous Cell Carcinoma: An Open-Label, Phase II Study.
Hu, Zhihuang; Sun, Si; Zhao, Xinmin; Yu, Hui; Wu, Xianghua; Wang, Jialei; Chang, Jianhua; Wang, Huijie.
Afiliação
  • Hu Z; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
  • Sun S; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
  • Zhao X; Institute of Thoracic Oncology, Fudan University, Shanghai, People's Republic of China.
  • Yu H; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
  • Wu X; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
  • Wang J; Institute of Thoracic Oncology, Fudan University, Shanghai, People's Republic of China.
  • Chang J; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
  • Wang H; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
Oncologist ; 27(4): 253-e312, 2022 04 05.
Article em En | MEDLINE | ID: mdl-35380726
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas do Esôfago Limite: Humans Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas do Esôfago Limite: Humans Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article